What is the current market price of a box of Oxiti?

Osimertinib (Osimertinib) is a drug used to treat EGFR gene mutation-positive non-small cell lung cancer (NSCLC) Targeted drugs, as the third generation EGFR-TKI, have the characteristics of penetrating the blood-brain barrier, precise target, and strong effectiveness of drug-resistant mutations (such as T790M). At present, the drug has been officially launched in China and has been included in the national medical insurance directory, providing a new treatment option for many lung cancer patients.

In the domestic market, the original drug of Osimertinib is produced by AstraZeneca (AstraZeneca) and is packaged in the format of 80mg*30 tablets. The price after medical insurance reimbursement is about five to six thousand yuan per box. Compared with the initial selling price of tens of thousands of yuan before being included in medical insurance, the current price is significantly lower, which greatly reduces the financial burden of patients. But even so, for some patients who need to take it for a long time, the monthly treatment cost is still a big burden.

In order to alleviate the high cost of treatment, some patients will also choose to purchase generic drugs through overseas channels. Currently, in Laos and Bangladesh, there are generic versions of osimertinib produced by regular pharmaceutical factories in both places. The active ingredients of these drugs are basically the same as the original drugs and the efficacy is similar. The price of generic drugs is more affordable to the people. The package price of 80mg*30 tablets is only a few hundred yuan, which greatly lowers the treatment threshold and is an important alternative for patients with limited financial conditions.

In general, the original version of Osimertinib is covered by medical insurance in China, and the price is about five to six thousand yuan, while the price of the generic version in Laos and Bangladesh is only a few hundred yuan. When selecting drugs, patients should comprehensively consider their condition needs, financial affordability, and the formality of drug channels to ensure both continuous treatment and drug safety. Rational use of medication under the guidance of a doctor is the key to obtaining good therapeutic effects.

Reference materials:https://go.drugbank.com/drugs/DB09330